arrow
返回
R

Richard G. Langley

Dalhousie University

77H指数
409论文数
2.7W被引数
收录论文 176
发表时间
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND特应性皮炎中度至重度患者接受特立珠单抗治疗长达6年的长期安全性与有效性:开放标签扩展试验ECZTEND的最终结果
err2026-02-05
err0
errOAAI
errAndrew Blauvelt; H. Chih-Ho Hong; Norito Katoh; Richard G. Langley; Vivian Laquer; Aleksandra Lesiak; Ketty Peris; Julien Seneschal; Juan-Francisco Silvestre; Richard B. Warren; Andreas Wollenberg; Matthew Zirwas; Niels Højsager Bennike; Farzaneh Safavimanesh; Ann-Marie Tindberg; Kristian Reich
err分享
err收藏
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals慢性累积性生命历程损伤是否被纳入银屑病管理?——一项针对银屑病患者和医疗保健专业人士的多国调查
err2025-11-22
err0
errOAAI
errRaymond Matthews; April W. Armstrong; Matthias Augustin; Christopher Baker; José Manuel Carrascosa; Brian Kirby; Richard Langley; Sandy McBride; Adam Reich; Ricardo Romiti; Francesca Sampogna; Richard B. Warren
err分享
err收藏
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis中重度特应性皮炎成人患者中曲尼司特长达4年的疗效
err2025-11-01
err1
errOAAI
errGooderham, Melinda; Ameen, Mahreen; Hong, H. Chih-ho; Katoh, Norito; Langley, Richard G.; Peris, Ketty; Reich, Kristian; Silvestre, Juan F.; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-marie; Oland, Christian Bjerregard; Blauvelt, Andrew
err分享
err收藏
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials特应性皮炎患者中特立洛金单抗的安全性(随访长达4.5年):一项八项临床试验的整合分析
err2025-11-01
err1
errOAAI
errReich, Kristian; Langley, Richard G.; Silvestre Salvador, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew E.; Paller, Amy S.; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Blauvelt, Andrew; Bjerregard Oland, Christian; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric L.
err分享
err收藏
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvementSPECTREM IIIb期临床 trial 结果(16周):guselkumab 治疗低体表面积、中度银屑病伴高影响部位受累的疗效与安全性
err2025-10-01
err1
errOAAI
errGold, Linda Stein; Gottlieb, Alice B.; Armstrong, April W.; Alkousakis, Theodore; Bissonnette, Robert; Langley, Richard G.; Krueger, James; Papp, Kim; Choi, Olivia; Rowland, Katelyn; Chan, Daphne; Jeyarajah, Jenny; Park-Wyllie, Laura; Gao, Long-Long; Gordon, Kenneth B.; Merola, Joseph F.; Lebwohl, Mark G.; Strober, Bruce
err分享
err收藏
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and AdultsDupilumab治疗婴幼儿、儿童、青少年及成人中重度特应性皮炎的安全性数据
err2025-09-24
err0
errOAAI
errRichard G. Langley; Guy Gherardi; Anna Coleman; Marius Ardeleanu; Ainara Rodríguez-Marco; Stephane Levy; Ashish Bansal; Zhen Chen; Ana B. Rossi; Brad Shumel; Faisal A. Khokhar
err分享
err收藏
Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-Analysis生物制剂和靶向治疗在银屑病中的作用起始时间:系统靶向文献综述和网络Meta分析
err2025-07-17
err0
errOAAI
errKim A. Papp; Ron Vender; Kerri Purdy; Fiona Lovegrove; Irina Oroz; Parbeer Grewal; Perla Lansang; Laura Park-Wyllie; Nastaran Abbarin; Ya-Wen Yang; Becky Hooper; Sandra Vigelis; Tim Disher; Richard G. Langley
err分享
err收藏
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trialBimekizumab在斑块状银屑病中至重度患者中的疗效持久性(至196周)和安全性(至4年):BE BRIGHT开放标签扩展试验结果
err2025-04-24
err0
errOAAI
errAndrew Blauvelt; Richard G. Langley; Mark Lebwohl; Bruce Strober; Richard B. Warren; Luis Puig; Akimichi Morita; Kenneth B. Gordon; Pablo Fernandez-Peñas; Sarah Kavanagh; José M. López Pinto; Jérémy Lambert; Bengt Hoepken; Delphine Deherder; Nancy Cross; Diamant Thaçi
err分享
err收藏
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector
err2025-03-01
err0
errOAAI
errSebastian, Michael; Bagel, Jerry; Hoepken, Bengt; Knapp, Bertram; Bicer, Ceyhun; MacPherson, Merran; Langley, Richard G.
err分享
err收藏
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)奥瑞司米拉斯特,一种磷酸二酯酶4B/D抑制剂,在轻中度特应性皮炎中的疗效与安全性:一项多中心随机安慰剂对照的IIb期剂量探索研究(ADESOS)的疗效与安全性
err2025-01-07
err2
PREAI
errSilverberg, Jonathan, I; Eichenfield, Lawrence F.; Blauvelt, Andrew; Irvine, Alan D.; Guttman-Yassky, Emma; Langley, Richard G.; Warren, Richard B.; French, Lars E.; Felding, Jakob; Weiss, Anne; Pedersen, Claus B.; Jensen, Morten L.; Carlsson, Anna; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric L.
err分享
err收藏
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus
err2024-08-16
err0
PREAI
errTorres, T.; Brembilla, N. C.; Langley, R. G.; Warren, R. B.; Thaci, D.; Kolios, A. G. A.; Prinz, J. C.; Londono-Garcia, A.; Nast, A.; Santin, M.; Goletti, D.; Abreu, M.; Spuls, P.; Boehncke, W. H.; Puig, L.
err分享
err收藏
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trialstralokinumab治疗治疗4.5年特应性皮炎患者的安全性: 对8项临床试验的最新综合分析
err2024-08-08
err0
PREAI
errReich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric
err分享
err收藏
Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)
err2024-08-08
err0
PREAI
errSilverberg, Jonathan; Eichenfield, Lawrence; Blauvelt, Andrew; Irvine, Alan D.; Langley, Richard; Guttman, Emma; Warren, Richard; French, Lars; Pedersen, Claus Bang; Carlsson, Anna; Jensen, Morten Lind; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric
err分享
err收藏
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
err2024-06-01
err0
PREAI
errChat, Vipawee S.; Ellebrecht, Christoph T.; Kingston, Paige; Gondo, George; Bell, Stacie; Cordoro, Kelly M.; Desai, Seemal R.; Duffin, Kristina C.; Feldman, Steven R.; Garg, Amit; Gelfand, Joel M.; Gladman, Dafna; Green, Lawrence J.; Gudjonsson, Johann; Han, George; Hawkes, Jason E.; Kircik, Leon; Koo, John; Langley, Richard; Lebwohl, Mark; Lewitt, G. Michael; Liao, Wilson; Martin, George; Orbai, Ana-Maria; Reddy, Soumya M.; Richardson, Veronica; Ritchlin, Christopher T.; Schwartzman, Sergio; Siegel, Evan L.; Van Voorhees, Abby S.; Wallace, Elizabeth B.; Weinberg, Jeffrey M.; Winthrop, Kevin L.; Yamauchi, Paul; Armstrong, April W.
err分享
err收藏
err分享
err收藏
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)Orismilast治疗中度至重度银屑病: 一项为期16周,随机,双盲,安慰剂对照,剂量发现和2b期试验 (IASOS) 的疗效和安全性
err2024-03-01
err5
errOAAI
errWarren, Richard B.; French, Lars E.; Blauvelt, Andrew; Langley, Richard G.; Egeberg, Alexander; Mrowietz, Ulrich; Hunter, Hamish J. A.; Gooderham, Melinda; Soerensen, Per; Andres, Philippe; Sommer, Morten O. A.; Carlsson, Anna; Kjoller, Kim D.; Strober, Bruce E.
err分享
err收藏
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trialstralokinumab治疗治疗4.5年特应性皮炎患者的安全性: 对8项临床试验的最新综合分析
err2024-02-07
err0
PREAI
errReich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric
err分享
err收藏
Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control持续tralokinumab治疗成人中度至重度特应性皮炎超过4年提供长期的疾病控制
err2024-02-07
err1
PREAI
errBlauvelt, Andrew; Langley, Richard G.; Peris, Ketty; Silvestre, Juan Francisco; Katoh, Norito; Tauber, Marie; Pinter, Andreas; Ameen, Mahreen; Gooderham, Melinda; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Reich, Kristian
err分享
err收藏
Using Artificial Intelligence as a Melanoma Screening Tool in Self-Referred Patients在自我推荐的患者中使用人工智能作为黑色素瘤筛查工具
err2023-12-29
err6
errOAAI
errCrawford, Madeleine E.; Kamali, Kiyana; Dorey, Rachel A.; Macintyre, Olivia C.; Cleminson, Kristyna; Macgillivary, Michael L.; Green, Peter J.; Langley, Richard G.; Purdy, Kerri S.; Decoste, Ryan C.; Gruchy, Jennette R.; Pasternak, Sylvia; Oakley, Amanda; Hull, Peter R.
err分享
err收藏